Viewing Study NCT00691028


Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2026-03-27 @ 1:09 PM
Study NCT ID: NCT00691028
Status: COMPLETED
Last Update Posted: 2014-03-04
First Post: 2008-06-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
Sponsor: Tanabe Pharma Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid Arthritis View
None RA View
None Infliximab View
None TA-650 View
None Remicade View